Price (delayed)
$11.6
Market cap
$160.3M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.05
Enterprise value
$164.32M
Champions Oncology is a data-driven research organization that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computational-based
There are no recent dividends present for CSBR.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.